Abstract

BackgroundAnkylosing spondylitis (AS) is a chronic, inflammatory rheumatic disease characterised by inflammatory back pain due to sacroiliitis and spondylitis. TNF-α blocking agents (infliximab, etanercept, adalimumab and golimumab) are effective in...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call